Cargando…
A PTG Variant Contributes to a Milder Phenotype in Lafora Disease
Lafora disease is an autosomal recessive form of progressive myoclonus epilepsy with no effective therapy. Although the outcome is always unfavorable, onset of symptoms and progression of the disease may vary. We aimed to identify modifier genes that may contribute to the clinical course of Lafora d...
Autores principales: | Guerrero, Rosa, Vernia, Santiago, Sanz, Raúl, Abreu-Rodríguez, Irene, Almaraz, Carmen, García-Hoyos, María, Michelucci, Roberto, Tassinari, Carlo Alberto, Riguzzi, Patrizia, Nobile, Carlo, Sanz, Pascual, Serratosa, José M., Gómez-Garre, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127956/ https://www.ncbi.nlm.nih.gov/pubmed/21738631 http://dx.doi.org/10.1371/journal.pone.0021294 |
Ejemplares similares
-
PTG Depletion Removes Lafora Bodies and Rescues the Fatal Epilepsy of Lafora Disease
por: Turnbull, Julie, et al.
Publicado: (2011) -
Treatment with metformin in twelve patients with Lafora disease
por: Bisulli, Francesca, et al.
Publicado: (2019) -
Increased Endoplasmic Reticulum Stress and Decreased Proteasomal Function in Lafora Disease Models Lacking the Phosphatase Laforin
por: Vernia, Santiago, et al.
Publicado: (2009) -
Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease
por: Sanz, Pascual, et al.
Publicado: (2021) -
Laforin, the most common protein mutated in Lafora disease, regulates autophagy
por: Aguado, Carmen, et al.
Publicado: (2010)